Aethlon Medical (NASDAQ: AEMD) reported Q3 EPS of ($0.16), $0.03 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $17.1 thousand versus the consensus estimate of $260 thousand.

For earnings history and earnings-related data on Aethlon Medical (AEMD) click here.